Current position:Home >Product >
(3-azanidyl-2-oxidanyl-propyl)azanide; platinum; 2-(2H-pyridin-1-id-2-yl)-2H-pyridin-1-ide; dichloride
(3-azanidyl-2-oxidanyl-propyl)azanide; platinum; 2-(2H-pyridin-1-id-2-yl)-2H-pyridin-1-ide; dichloride
|
|
Canonical SMILES:
C1=CC([N-]C=C1)C2C=CC=C[N-]2.C(C(C[NH-])O)[NH-].[Cl-].[Cl-].[Pt]
Isomeric SMILES
C1=CC([N-]C=C1)C2C=CC=C[N-]2.C(C(C[NH-])O)[NH-].[Cl-].[Cl-].[Pt]
InChI
InChI=1S/C10H10N2.C3H8N2O.2ClH.Pt/c1-3-7-11-9(5-1)10-6-2-4-8-12-10;4-1-3(6)2-5;;;/h1-10H;3-6H,1-2H2;2*1H;/q2*-2;;;/p-2
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- (3S,6R,10R,13E,16S)-10-[(4-methoxyphenyl)methyl]-6-methyl-3-(2-methylpropyl)-16-[(E)-1-oxidanyl-3-phenyl-prop-2-enyl]-1,4-dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone
- N-[(E,2S,3R)-1-[(2R,4R,5S)-5-[(2S,4S,5S)-4-[(2S,4R,5S)-3-acetamido-5-[(2S,4S,5S)-4-[(2S,4R,5S)-3-acetamido-5-[(2S,4S,5S)-4-[(2S,4R,5S)-3-acetamido-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-yl]oxy-6-(hydroxymethyl)-3,5-bis(oxidanyl)oxan-2-yl]oxy-6-(hydroxymethyl)-4-oxidanyl-oxan-2-yl]oxy-6-[[(2R,4R,5S)-3-acetamido-6-(hydroxymethyl)-5-[(2S,4S,5S)-6-(hydroxymethyl)-4-[(2S,4S,5R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-3,5-bis(oxidanyl)oxan-2-yl]oxy-4-oxidanyl-oxan-2-yl]oxymethyl]-3,5-bis(oxidanyl)o
- [(E)-1-[(3S,6R,10R,13E,16S)-10-[(4-methoxyphenyl)methyl]-6-methyl-3-(2-methylpropyl)-2,5,9,12-tetrakis(oxidanylidene)-1,4-dioxa-8,11-diazacyclohexadec-13-en-16-yl]-3-phenyl-prop-2-enyl] ethanoate
- N-[(E,2S,3R)-1-[(2R,4R,5S)-5-[(2S,4S,5S)-4-[(2S,4R,5S)-3-acetamido-5-[(2S,4S,5S)-4-[(2S,4R,5S)-3-acetamido-5-[(2S,4S,5S)-4-[(2S,4R,5S)-3-acetamido-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-yl]oxy-6-(hydroxymethyl)-3,5-bis(oxidanyl)oxan-2-yl]oxy-6-(hydroxymethyl)-4-oxidanyl-oxan-2-yl]oxy-6-[[(2R,4R,5S)-3-acetamido-6-(hydroxymethyl)-5-[(2S,4S,5S)-6-(hydroxymethyl)-4-[(2S,4S,5R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-3,5-bis(oxidanyl)oxan-2-yl]oxy-4-oxidanyl-oxan-2-yl]oxymethyl]-3,5-bis(oxidanyl)o
- (NZ)-N-(4H-imidazo[2,1-c][1,4]benzoxazin-2-ylmethylidene)hydroxylamine
- (diphenylmethyl) (7R)-3-(acetyloxymethyl)-7-(1,3-benzothiazol-2-ylamino)-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- N-[(E,2S,3R)-1-[(2R,4R,5S)-5-[(2S,4S,5S)-4-[(2S,4R,5S)-3-acetamido-5-[(2S,4S,5S)-4-[(2S,4R,5S)-3-acetamido-5-[(2S,4S,5S)-4-[(2S,4R,5S)-3-acetamido-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-yl]oxy-6-(hydroxymethyl)-3,5-bis(oxidanyl)oxan-2-yl]oxy-6-(hydroxymethyl)-4-oxidanyl-oxan-2-yl]oxy-6-[[(2R,4R,5S)-3-acetamido-6-(hydroxymethyl)-5-[(2S,4S,5S)-6-(hydroxymethyl)-4-[(2S,4S,5R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-3,5-bis(oxidanyl)oxan-2-yl]oxy-4-oxidanyl-oxan-2-yl]oxymethyl]-3,5-bis(oxidanyl)o
- (E)-but-2-enedioic acid; N-[4-[4-[ethyl(6-fluoranylheptyl)amino]-1-oxidanyl-butyl]phenyl]methanesulfonamide
- (3S,10R,13E,16S)-10-[(4-methoxyphenyl)methyl]-3-(2-methylpropyl)-16-(3-phenylpropanoyl)-1,4-dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone
- N-[(E,2S,3R)-1-[(2R,4R,5S)-5-[(2S,4S,5S)-4-[(2S,4R,5S)-3-acetamido-5-[(2S,4S,5S)-4-[(2S,4R,5S)-3-acetamido-5-[(2S,4S,5S)-4-[(2S,4R,5S)-3-acetamido-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-yl]oxy-6-(hydroxymethyl)-3,5-bis(oxidanyl)oxan-2-yl]oxy-6-(hydroxymethyl)-4-oxidanyl-oxan-2-yl]oxy-6-[[(2R,4R,5S)-3-acetamido-6-(hydroxymethyl)-5-[(2S,4S,5S)-6-(hydroxymethyl)-4-[(2S,4S,5R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-3,5-bis(oxidanyl)oxan-2-yl]oxy-4-oxidanyl-oxan-2-yl]oxymethyl]-3,5-bis(oxidanyl)o

